Naim Alkhouri

机构：North Shore University Hospital, Summit Medical Group (United States), Cleveland Research (United States), Pinnacle Clinical Research, Conceptual Mindworks (United States), Ohio Aerospace Institute, Global Health Council · ORCID：0000-0001-9872-2391

发表论文 678 篇 · 总被引 22713 次 · h-index 76

代表论文

• Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study (2025 · The Lancet · 被引 28)
• Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ NASH Trial (2025 · Alimentary Pharmacology & Therapeutics · 被引 19)
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study (2025 · Hepatology · 被引 12)
• Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study (2025 · Hepatology · 被引 10)
• A call to action from the Global Think-tank on Steatotic Liver Disease (2026 · Nature Health · 被引 4)
• Propelling MASLD trials into the era of non-invasive tests (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 1)